STIM1 and osteosarcoma: Moreover, we found that cisplatin decreased Stim1 expression and SOCE in MG63 cells, but not in their resistant variants, further suggesting that increased Stim1 expression and subsequent SOCE may be a determinant of cisplatin resistance in osteosarcoma cells.